Latest Board Of Directors News

Aspermont Limited's trading suspension has been lifted following a key announcement about new board appointments, signaling a fresh chapter for the media publisher.

Aspermont Limited’s shares have been suspended from trading due to a critical shortfall in board directors, raising questions about its governance and future compliance.

James Hardie Industries has appointed Nigel Stein as the new Chair of its Board and established an Integration and Performance Committee to oversee the AZEK acquisition integration and enhance shareholder engagement.

Robex Resources has filed a management information circular ahead of a December 15 shareholder vote on a proposed acquisition by Predictive Discovery. The deal promises to create a West African gold mining powerhouse.

SSH Group has completed a $2.53 million strategic placement with Xinhai Mining Services, welcoming the global EPC+M+O leader as a 15.5% cornerstone shareholder and setting the stage for accelerated growth.

Admiralty Resources NL reported a mixed cash flow quarter ending September 2025, balancing operating outflows with investing and financing inflows to maintain a solid funding runway.

MEC Resources has advanced its investment in Advent Energy and issued shares to directors, while its PEP 11 Joint Venture faces ongoing legal scrutiny ahead of a Federal Court hearing.

Openn Negotiation Ltd remains suspended from ASX trading but has secured interest-free loans from its major shareholder to support working capital as it explores strategic options post-DOCA.

TZ Limited has turned down a non-binding offer from Quadient SA for its US Smart Locker subsidiary, Telezygology Inc., citing undervaluation and strategic importance of its Data Centre Security division. The company is now initiating a strategic review to explore future options for the business.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Multistack International Limited has announced plans to discontinue its current business operations due to sustained losses and capital constraints, with a strategic disposal of its Australian subsidiary underway.